Tyramine Dosing: Weight-Based Measurement, Not Packets
Tyramine is dosed and measured by weight in milligrams (mg) or grams (g), not by packets. In clinical research and pharmacokinetic studies, tyramine is administered as a specific weight-based dose, typically ranging from 200-400 mg for oral challenge testing 1, 2.
Clinical Context and Dosing
Research and Challenge Testing
- Standard oral tyramine challenge dose: 200-400 mg administered as a single dose 1, 2
- In pharmacokinetic studies, a 400 mg dose was used to evaluate tyramine metabolism and blood pressure effects 2
- A 200 mg dose was used to compare fasted versus fed states 1
Tyramine Pressor Testing (with MAOIs)
When evaluating tyramine sensitivity in patients on monoamine oxidase inhibitors (MAOIs), standardized oral tyramine pressor tests use incremental weight-based dosing:
- The "TYR 30" dose (amount needed to raise standing blood pressure by ≥30 mmHg) varies significantly based on MAOI type 3
- With moclobemide: mean TYR 30 dose was 306 mg 3
- With tranylcypromine: mean TYR 30 dose was only 35 mg 3
Dietary Tyramine Content (For Context)
While tyramine is not dispensed in packets for therapeutic use, understanding food content helps contextualize dosing:
High-Risk Foods (≥6 mg/serving)
- Chicken liver (aged 9 days): 63.84 mg per 30g serving 4
- Air-dried sausage: 7.56 mg per 30g serving 4
- Sauerkraut: 7.75 mg per 250g serving 4
- Soy sauce: 0.941 mg/mL 4
Clinical Thresholds
- 6 mg tyramine: May produce mild hypertensive crisis 5
- 10-25 mg tyramine: May produce severe headaches with potential intracranial hemorrhage 5
- Safe threshold for MAOI patients: Keep tyramine intake below 5 mg 5
Important Caveats
Food administration significantly reduces tyramine bioavailability: When tyramine is administered with a meal versus fasted state, systemic exposure is reduced by 53% and maximum concentration by 72% 1. This explains why approximately twice the amount of tyramine is required when administered with food to elicit the same pressor effect 1, 3.
Highly variable pharmacokinetics: There is strong interindividual variation in systemic tyramine exposure, with mean clearance of 107 L/min and approximately 76.8% of the dose recovered in urine as the MAO-A metabolite 4-hydroxyphenylacetic acid 2.
Practical Application
For patients on MAOIs 6, 7, 8:
- Avoid consumption of large amounts of tyramine-rich foods 6
- Avoid tyramine-containing foods with MAOIs 7
- The lowest TYR 30 dose during moclobemide treatment is at least 150 mg tyramine (contained in approximately 300g strong cheese or 100g yeast extract) 3
- For tranylcypromine, the TYR 30 dose is only 20 mg tyramine (contained in approximately 40g strong cheese) 3